Fresenius Medical Care (FMS) has disclosed a new risk, in the International Operations category.
Fresenius Medical Care, with its extensive global reach, is exposed to a complex array of risks stemming from its operations. Economic volatility, political instability, and geopolitical conflicts, such as the ongoing Ukraine War, can significantly impact profitability and asset values. Furthermore, challenges like enforcing receivables, navigating local ownership laws, and facing increased tariffs and trade restrictions compound their risk profile. These factors, alongside potential intellectual property protection issues and sanctions-related constraints in certain territories, could materially and adversely affect the company’s financial health and operational continuity.
The average FMS stock price target is $20.46, implying -0.78% downside potential.
To learn more about Fresenius Medical Care’s risk factors, click here.
